An internal standard for the quantification of 1-stearoyl-rac-glycerol
Related Products
Unlabeled Version(s)
268271-Stearoyl-rac-glycerol
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

1-Stearoyl-rac-glycerol-d40

Item No. 28919

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
octadecanoic-2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-d35 acid, 2,3-dihydroxypropyl-1,1,2,3,3-d5 ester
CAS Number
2692624-09-0
Synonyms
  • 18:0-d40-MG
  • 1-Monostearin-d40
  • MG(18:0-d40/0:0/0:0)
Molecular Formula
C21H2D40O4
Formula Weight
398.8
Purity
≥99% deuterated forms (d1-d40)
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
Chloroform: 50 mg/ml
SMILES
O=C(C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])OC([2H])([2H])C(O)([2H])C([2H])([2H])O
InChi Code
InChI=1S/C21H42O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-21(24)25-19-20(23)18-22/h20,22-23H,2-19H2,1H3/i1D3,2D2,3D2,4D2,5D2,6D2,7D2,8D2,9D2,10D2,11D2,12D2,13D2,14D2,15D2,16D2,17D2,18D2,19D2,20D
InChi Key
VBICKXHEKHSIBG-UHFXHMRYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $41

    Add

    1 mg

    $75

    Add

    5 mg

    $332

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    1-Stearoyl-rac-glycerol-d40 is intended for use as an internal standard for the quantification of 1-stearoyl-rac-glycerol (Item No. 26827) by GC- or LC-MS. 1-Stearoyl-rac-glycerol is a monoacylglycerol that contains stearic acid (Item No. 10011298) at the sn-1 position. 1-Stearoyl-rac-glycerol levels are decreased in tumor tissue in a mouse model of azoxymethane-induced colorectal carcinogenesis.1 Levels of 1-stearoyl-rac-glycerol are decreased in lung tissue from patients with adenocarcinoma, but are increased in the serum of patients with Buruli ulcer and in the cerebrospinal fluid of patients with the inflammatory demyelinating diseases multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (ITM).2,3,4 1-Stearoyl-rac-glycerol has been used in the composition of transfersomes for transdermal delivery of doxorubicin (Item No. 15007) in rats, leading to doxorubicin accumulation in lymph nodes, spleen, and heart.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Montrose, D.C., Zhou, X.K., Kopelovich, L., et al. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev. Res. (Phila.) 5(12), 1358-1367 (2012).

    2. Wikoff, W.R., Grapov, D., Fahrmann, J.F., et al. Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma. Cancer Prev. Res. (Phila.) 8(5), 410-418 (2015).

    3. Niang, F., Sarfo, F.S., Frimpong, M., et al. Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease. Sci. Rep. 5:17693, (2015).

    4. Park, S.J., Jeong, I.H., Kong, B.S., et al. Disease type- and status-specific alteration of CSF metabolome coordinated with clinical parameters in inflammatory demyelinating diseases of CNS. PLoS One 11(11), e0166277 (2016).

    5. Kong, M., Hou, L., Wang, J., et al. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy. Chem. Commun. (Camb.) 51(8), 1453-1456 (2015).